BUDA
Buda Juice Inc.
BUDA trails on the overall score without a compensating advantage in the available component scores.
CELH
Celsius Holdings, Inc.
CELH has the edge over BUDA overall, supported by stronger fundamentals and stronger valuation.
BUDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
BUDA's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BUDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 34x | $6.49 | -4.9% |
| Current | 35x | $6.83 | — |
| Fair | 39x | $7.41 | +8.5% |
| Expensive | 41x | $7.88 | +15% |
Historical ranges are pointers, not guarantees.
BUDA has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BUDA Forward outlook
There aren't enough analyst estimates for BUDA to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BUDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.19 | -27% |
| Q1 2026 | $0.24 | +33% |
| Q4 2025 | $0.26 | +117% |
BUDA's earnings per share have fallen from their peak: $0.19 over the past year, against $0.26 in mid-2025.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BUDA in the latest year-over-year earnings comparison.
BUDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.5M | +26% |
| Q1 2026 | $3.5M | +18% |
| Q4 2025 | $2.9M | +4.4% |
| Q3 2025 | $3.2M | +9.1% |
| Q2 2025 | $3.6M | +27% |
| Q1 2025 | $3M | +6.5% |
BUDA's revenue has grown year over year every quarter since early 2025: $5M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9.8% | -22 points |
| Q1 2026 | 17% | -10 points |
| Q4 2025 | 23% | -7.9 points |
| Q3 2025 | 27% | -0.7 points |
| Q2 2025 | 32% | +0.8 points |
| Q1 2025 | 27% | -4.3 points |
| Q4 2024 | 31% | N/A |
| Q3 2024 | 28% | N/A |
BUDA's operating margin was 9.8% last quarter, down 22 points from the same quarter a year ago, near the bottom of its range since 2024.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BUDA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BUDA on profitability, with a higher operating margin.
BUDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$247K | -131% |
| Q1 2026 | $1.1M | +42% |
| Q4 2025 | $547K | -50% |
| Q3 2025 | $794K | +0.6% |
| Q2 2025 | $798K | +13% |
| Q1 2025 | $765K | +8.7% |
BUDA has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BUDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -6.3x | Net Cash |
| Q1 2026 | -5.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.5x | Net Cash |
BUDA has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BUDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 14.5 | Oversold |
BUDA's weekly RSI is 44 (neutral) and its Stochastic is 15 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BUDA PE vs Consumer Defensive Sector
| Metric | BUDA | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 81% above |
BUDA has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BUDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.10 | 3.8% below |
| 20 week MA | $8.05 | 15% below |
CELH has stronger trend alignment. BUDA is above 0 of 2 weekly averages versus CELH above 2 of 5.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BUDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $8.15 | $6.83 | -16% |
BUDA has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.